Mefloquine Hydrochloride Tablet
Product Images NDC 0555-0171

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mefloquine Hydrochloride (NDC 0555-0171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of mefloquine hydrochloride showing its molecular composition and arrangement including trifluoromethyl groups, hydroxyl group, and a piperidine ring with hydrochloride association.*

FDA Label Image

Image 2

Packaging label for Mefloquine Hydrochloride Tablets USP 250 mg, an oral tablet by Teva Pharmaceuticals USA, Inc. The label shows the product strength as 250 mg and package contains 25 unit-dose tablets arranged as 5 x 5. The label includes the NDC 0555-0171-78 and a barcode. It instructs pharmacists to dispense the enclosed medication guide to each patient.*

FDA Label Image

Image 3

Packaging label for Mefloquine Hydrochloride Tablets USP 250 mg by Teva Pharmaceuticals USA, Inc. The label indicates the product contains 25 unit-dose tablets (5 x 5) and includes storage instructions and a warning that the package is not for household use. The label also displays NDC 0555-0171-78 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.